Emulate
Emulate, Inc.: A Boston-based biotech firm innovating with Organs-on-Chips technology for precision medicine and product testing.
Founded
2013Emulate, Inc.: A Boston-based biotech firm innovating with Organs-on-Chips technology for precision medicine and product testing.
emulatebio.comCrawled Oct 15, 2026
The page describes how 2D cell culture models led to Organ-on-a-Chip technology and other 3D cell culture models.
The page discusses how the FDA, NIH, and Congress are advancing alternatives to animal testing and how Organ-on-a-Chip technology is changing drug development.
The page describes how scientists used an intestine Organ-Chip model to study mechanisms underlying colorectal cancer and support research and therapeutic development.
The abstract describes organ-on-chip systems that use human cells to model tissue structure, organ-level function, and disease phenotypes.
The page discusses a congressional hearing on issues with animal testing in biomedical research and alternatives to animal models.
Platform adopted by 10 of the top 25 biopharmaceutical companies, by U.S. governmental agencies, and by academic research centers worldwide
Emulate’s Duodenum Intestine-Chip provides a robust system for preclinical drug assessment of drug transport, metabolism, and drug-drug interactions in the intestine
Agency-wide CRADA agreement also includes studies with Brain-Chip in Alzheimer’s disease, Intestine-Chip in microbiome health, and Liver-Chip in individualized toxicity responses
The page lists available career opportunities and provides information about joining the team.
Proceeds will expand product suite and commercialization of Human Emulation System as a comprehensive platform for use across the entire drug discovery and development process
The page describes testing drug candidates in a human-relevant model before animal studies to assess clinical safety.
Emulate uses Organ-on-a-Chip technology and provides information about its company and team.
Contact HQ for questions regarding media relations, finance, and careers.
The page describes Organ-on-a-Chip technology that allows researchers to emulate biology and predict human response.
Emulate, Inc. and its subsidiaries (Emulate) state a commitment to protecting the privacy and security of information provided through interactions with their websites, including emulatebio.com.
Emulate, a month-old UK AI startup founded by former Google DeepMind researchers, is in advanced talks to raise as much as $700 million at a $3.7 billion valuation. Its founders are researchers leaving the Big Tech group’s London lab.
Sep 2026 · Financial TimesNews article
Emulate launches Brain-Chip R1, a first-in-class isogenic model of the human neurovascular unit developed with FUJIFILM Cellular Dynamics. The model supports studies of blood-brain barrier drug transport and neuroinflammation in central nervous system drug discovery.
Nov 2025 · Emulate, Inc.News article
The FDA accepts the first letter of intent for an organ-on-a-chip technology into its ISTAND Pilot Program, marking the program's first such submission. The human Liver-Chip is a drug development tool designed to assess the risk of drug-induced liver injury in drug candidates.
Sep 2024 · U.S. Food and Drug AdministrationNews article
Emulate introduced the Zoë-CM2 culture module, a second-generation instrument for its Human Emulation System. The module prolongs cell life within Emulate’s organ chips and automates culturing conditions for up to 12 chips.
Jan 2024 · Drug Discovery & DevelopmentNews article